Literature DB >> 25398105

MARCKS is marked in combating lung cancer growth and acquired resistance.

Sekhar P Reddy1, Viswanathan Natarajan, Arkadiusz Z Dudek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25398105      PMCID： PMC4299642          DOI： 10.1164/rccm.201410-1922ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  14 in total

1.  AACR Cancer Progress Report 2014.

Authors:  Carlos L Arteaga; Peter C Adamson; Jeffrey A Engelman; Margaret Foti; Richard B Gaynor; Susan G Hilsenbeck; Paul J Limburg; Scott W Lowe; Elaine R Mardis; Scott Ramsey; Timothy R Rebbeck; Andrea L Richardson; Eric H Rubin; George J Weiner
Journal:  Clin Cancer Res       Date:  2014-09-16       Impact factor: 12.531

2.  Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.

Authors:  Ching-Hsien Chen; Sarah Statt; Chun-Lung Chiu; Philip Thai; Muhammad Arif; Kenneth B Adler; Reen Wu
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

Review 3.  Targeting phosphoinositide 3-kinase signalling in lung cancer.

Authors:  Anna Wojtalla; Alexandre Arcaro
Journal:  Crit Rev Oncol Hematol       Date:  2011-02-11       Impact factor: 6.312

Review 4.  Plasma membrane phosphoinositide organization by protein electrostatics.

Authors:  Stuart McLaughlin; Diana Murray
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

Review 5.  Targeting PI3K signalling in cancer: opportunities, challenges and limitations.

Authors:  Jeffrey A Engelman
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

6.  Localization of the MARCKS (87 kDa) protein, a major specific substrate for protein kinase C, in rat brain.

Authors:  C C Ouimet; J K Wang; S I Walaas; K A Albert; P Greengard
Journal:  J Neurosci       Date:  1990-05       Impact factor: 6.167

7.  Protein kinase C substrate and inhibitor characteristics of peptides derived from the myristoylated alanine-rich C kinase substrate (MARCKS) protein phosphorylation site domain.

Authors:  J M Graff; R R Rajan; R R Randall; A C Nairn; P J Blackshear
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

Review 8.  Inhibition of PI-3 kinase for treating respiratory disease: good idea or bad idea?

Authors:  Matt Thomas; Charles Owen
Journal:  Curr Opin Pharmacol       Date:  2008-04-03       Impact factor: 5.547

9.  Electrostatic sequestration of PIP2 on phospholipid membranes by basic/aromatic regions of proteins.

Authors:  Alok Gambhir; Gyöngyi Hangyás-Mihályné; Irina Zaitseva; David S Cafiso; Jiyao Wang; Diana Murray; Srinivas N Pentyala; Steven O Smith; Stuart McLaughlin
Journal:  Biophys J       Date:  2004-04       Impact factor: 4.033

10.  Protein kinase C delta regulates airway mucin secretion via phosphorylation of MARCKS protein.

Authors:  Jin-Ah Park; Anne L Crews; William R Lampe; Shijing Fang; Joungjoa Park; Kenneth B Adler
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307
View more
  3 in total

1.  Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment.

Authors:  Ching-Hsien Chen; Chun-Ting Cheng; Yuan Yuan; Jing Zhai; Muhammad Arif; Lon Wolf R Fong; Reen Wu; David K Ann
Journal:  Oncotarget       Date:  2015-06-20

2.  Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma.

Authors:  Akifumi Uchida; Naohiko Seki; Keiko Mizuno; Shunsuke Misono; Yasutaka Yamada; Naoko Kikkawa; Hiroki Sanada; Tomohiro Kumamoto; Takayuki Suetsugu; Hiromasa Inoue
Journal:  Cancer Sci       Date:  2018-12-06       Impact factor: 6.716

3.  Expression Level and Clinical Significance of AK021443 in Non-Small-Cell Lung Carcinoma.

Authors:  Xiyong Wang; Yu Dai; Hongming Zhang; Honglin Xia; Qingsheng Kan
Journal:  J Healthc Eng       Date:  2022-03-14       Impact factor: 2.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.